Trials Offered by a Specific Doctor

HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Daniel Lee, MD
Phone
212-317-5077
Email
djl2164@cumc.columbia.edu
(Biography not available)

Clinical Studies Managed By Dr. Lee:
More InfoTitleSponsorIRB Number
DetailsA study for patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)Tolero Pharmaceuticals, Inc.AAAQ7667
Details[CLOSED] A study for patients with acute myeloid leukemia using study drug Venetoclax in combination with AzacitidineAbbVie, Inc.AAAR1251
Details[CLOSED] Study of sertraline (Zoloft) with ara-C in combination in patients with acute myeloid leukemia (AML)InternalAAAQ8444
Details[CLOSED] Study of Drug in Patients with Acute Myeloid Leukemia (AML)Tolero PharmaceuticalsAAAR4394
DetailsStudy of Experimental Drug in Patients with Hematological Malignancies (Blood Cancers)Forty Seven, Inc.AAAR4923
DetailsStudy of Alvocidib When Administered in Sequence After Decitabine in Patients with Myeolodysplastic Syndromes (MDS)Tolero PharmaceuticalsAAAR9983
DetailsA Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered With Hu5F9-G4 to Patients With Acute Myeloid LeukemiaF. Hoffmann - La Roche LtdAAAS3836
DetailsA Study of MBG453 in Combination With Hypomethylating Agents in Subjects With Myelodysplastic Syndrome (MDS)Novartis PharmaceuticalsAAAS4107
DetailsStudy of Alvocidib in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Treatment with Venetoclax Combination TherapyTolero Pharmaceuticals, Inc.AAAS6739